Results 81 to 90 of about 166,181 (302)

Treatment of Lupus Erythematosus of the Eyelids with Pulsed Dye Laser [PDF]

, 2016
info:eu-repo/semantics ...
Boixeda, P, Brás, S, Gonzalez, B, Segurado-Miravalles, G   +3 more
core   +1 more source

Lupus mastitis and antiphospholipid syndrome treated with anticoagulation and immunosuppression: a case report

Journal of Medical Case Reports, 2023
Background Systemic lupus erythematosus is an autoimmune disease that can have cutaneous and systemic manifestations. Lupus panniculitis, also known as lupus mastitis, is a subset of chronic cutaneous lupus erythematosus that involves inflammation of the
Lauren J. He, Laarni C. Quimson, Oluwakemi Onajin, Kimberly C. Trotter   +3 more
doaj   +1 more source

A cooperative release of mitochondrial DNA from platelets and neutrophils drives an interferon signature in systemic sclerosis

Arthritis &Rheumatology, Accepted Article.
Objective Mitochondria are organelles with a hypomethylated circular genome. Mitochondrial DNA (mtDNA) in the systemic circulation has been implicated in inflammation. This study investigates the role of circulating DNA in systemic sclerosis (SSc) and the cellular mechanisms governing its release.
Stavros Giaglis, André N. Tiaden, Simone Häner‐Massimi, Diego Kyburz, Cedric André, Anton Glück, Enrico Ferrero, Stuart Hawtin, Tobias Junt, Ulrich A. Walker   +9 more
wiley   +1 more source

Would You Recognize Lupus? [PDF]

, 2018
Systemic Lupus Erythematosus, or SLE, is a chronic autoimmune disease which significantly affects various organs of the body and the oral cavity. According to various studies, SLE can cause an increased risk of periodontitis, fungal infections, and ...
Brown, Barbara, Simms, Maegan, Smith, Sydney C   +2 more
core   +1 more source

Lupus profundus limited to a site of trauma: Case report and review of the literature

International Journal of Women's Dermatology, 2017
Lupus erythematosus profundus (LEP) is a rare form of chronic cutaneous lupus erythematosus. We report on a case of a 56-year-old Caucasian woman who presented with a single, persistent, painful rash on the left hip and lateral aspect of the left upper ...
María Adriana Castrillón, MD, Dédée F. Murrell, MA, BMBCh, MD, FAAD, FACD, FRCP (Edin)   +1 more
doaj   +1 more source

Utility of CD123 immunohistochemistry in differentiating lupus erythematosus from cutaneous T cell lymphoma

Histopathology, 2019
Histopathological overlap between lupus erythematosus and certain types of cutaneous T cell lymphoma (CTCL) is well documented. CD123+ plasmacytoid dendritic cells (PDCs) are typically increased in lupus erythematosus, but have not been well studied in ...
Stephanie J T Chen, J. Tse, P. Harms, A. Hristov, M. Chan   +4 more
semanticscholar   +1 more source

Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: the Randomized, Phase 3, TULIP‐SC Study

Arthritis &Rheumatology, Accepted Article.
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate‐to‐severe SLE activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly for 52 weeks (1:1 ...
Susan Manzi, Ian N. Bruce, Eric F. Morand, Richard Furie, Yoshiya Tanaka, Kenneth C. Kalunian, Anca Askanase, Patricia Puzio, Emon Khan, Jenny Wissmar, Michael Song, Catharina Lindholm, The TULIP‐SC investigators   +12 more
wiley   +1 more source

Longitudinal fluctuation of anti-lipoprotein lipase antibody is related with disease activity in systemic lupus erythematosus patients without anti-dsDNA antibodies [PDF]

, 2009
INTRODUÇÃO: O Lúpus Eritematoso Sistêmico (LES) se caracteriza por períodos de exacerbação e remissão clínica que frequentemente são acompanhados por alterações nos níveis séricos de anticorpos específicos, como o anti-dsDNA, que está presente em 40% dos
BONFÁ, Eloísa, BORBA NETO, Eduardo Ferreira, BUENO, Cleonice, CARVALHO, Jozélio Freire de, LEON, Elaine Pires, VIANA, Vilma Santos Trindade   +5 more
core   +2 more sources

Lúpus eritematoso cutâneo: aspectos clínicos e laboratoriais Cutaneous lupus erythematosus: clinical and laboratory aspects

Anais Brasileiros de Dermatologia, 2005
O lúpus eritematoso é doença auto-imune do tecido conjuntivo que reúne manifestações exclusivamente cutâneas ou multissistêmicas, podendo apresentar exuberância de auto-anticorpos.
Alceu Luiz Camargo Villela Berbert, Sônia Antunes de Oliveira Mantese   +1 more
doaj   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source